Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Hindu
The Hindu
National
Bindu Shajan Perappadan

Experts question Ministry on reversal of provisions targeting inappropriate AYUSH advertisements

The Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homeopathy (AYUSH) Ministry’s apparent U-turn on its stance - specifically for controlling inappropriate advertisements of Ayurvedic, Siddha and Unani medicines - has come under criticism from health experts who have now approached the Ministry for urgent intervention and possible reversal of its recommendation.

The Ayurvedic Siddha and Unani Drugs Technical Advisory Board (ASUBTAB) has recommended the omission of Rule 170 which deals with controlling inappropriate advertisements and was previously brought into the Central Government notified amendment of the Drugs & Cosmetics Rules, 1945, on December 24, 2018.

The Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954, encompasses the provisions for prohibition of misleading advertisements and exaggerated claims of drugs and medicinal substances including AYUSH medicines and for the penalty to be imposed on the defaulters.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.